Loading…
Based on limited metadata without access to the full warning letter text, the FDA issued a warning to Tender Corporation on July 23, 2020, regarding drug products under its jurisdiction. While the specific violations cannot be determined from the available information, the warning indicates that the company's drug manufacturing, marketing, or compliance practices did not meet FDA regulatory standards. The exact nature of the violations and the specific issuing FDA office are not specified in the metadata provided.